Cardiotrophin-like cytokine factor 1 (CLCF1) and neuropoietin (NP) signalling and their roles in development, adulthood, cancer and degenerative disorders

Cytokine and Growth Factor Reviews

Volumn 26, Issue 5, 2015, Pages 517-522

  Sims, Natalie A ^a,b  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cardiotrophin like cytokine; Ciliary neurotrophic factor receptor; Gp130; IL 6; Neuropoietin; STAT

Indexed keywords

AGGRECANASE 2; CARDIOTROPHIN 1; CARDIOTROPHIN LIKE CYTOKINE FACTOR 1; CILIARY NEUROTROPHIC FACTOR RECEPTOR; CYTOKINE; CYTOKINE RECEPTOR LIKE FACTOR 1; INTERLEUKIN 12; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; NEUROPOIETIN; PROTEIN P28; SORTILIN; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CILIARY NEUROTROPHIC FACTOR RECEPTOR ALPHA; CLCF-1 PROTEIN, HUMAN; CNTFR PROTEIN, HUMAN; GLYCOPROTEIN GP 130; IL27 PROTEIN, HUMAN; IL6ST PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; NEUROPOIETIN, MOUSE; TUMOR PROTEIN;

ADIPOGENESIS; ADULTHOOD; BINDING AFFINITY; CANCER GROWTH; CELL DIFFERENTIATION; CELL FUNCTION; DEGENERATIVE DISEASE; GENE MUTATION; HEMATOPOIESIS; HUMAN; IMMUNOCOMPETENT CELL; KIDNEY DEVELOPMENT; KIDNEY DISEASE; LUNG CANCER; LUNG FIBROSIS; LUNG FUNCTION; MUSCULOSKELETAL SYSTEM; MYELODYSPLASTIC SYNDROME; NEOPLASM; NERVE DEGENERATION; NERVOUS SYSTEM; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SHORT SURVEY; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; FACIES; FEVER; GENETICS; HAND MALFORMATION; IMMUNOLOGY; MOUSE; MUSCLE CONTRACTION; SUDDEN DEATH; TRISMUS;

ANIMALS; CILIARY NEUROTROPHIC FACTOR RECEPTOR ALPHA SUBUNIT; CYTOKINE RECEPTOR GP130; CYTOKINES; DEATH, SUDDEN; FACIES; FEVER; HAND DEFORMITIES, CONGENITAL; HUMANS; INTERLEUKIN-6; INTERLEUKINS; MICE; MUSCLE CONTRACTION; NEOPLASM PROTEINS; NEOPLASMS; TRISMUS;

EID: 84941943727     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2015.07.014     Document Type: Short Survey

References (68)

1. Elson G.C., Lelievre E., Guillet C., Chevalier S., Plun-Favreau H., Froger J., et al. CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex. Nat. Neurosci. 2000, 3:867-872.
2. Senaldi G., Varnum B.C., Sarmiento U., Starnes C., Lile J., Scully S., et al. Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:11458-11463.
3. Shi Y., Wang W., Yourey P.A., Gohari S., Zukauskas D., Zhang J., et al. Computational EST database analysis identifies a novel member of the neuropoietic cytokine family. Biochem. Biophys. Res. Commun. 1999, 262:132-138.
4. Derouet D., Rousseau F., Alfonsi F., Froger J., Hermann J., Barbier F., et al. Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:4827-4832.
5. Rousseau F., Chevalier S., Guillet C., Ravon E., Diveu C., Froger J., et al. Ciliary neurotrophic factor, cardiotrophin-like cytokine, and neuropoietin share a conserved binding site on the ciliary neurotrophic factor receptor α chain. J. Biol. Chem. 2008, 283:30341-30350.
6. Plun-Favreau H., Elson G., Chabbert M., Froger J., deLapeyriere O., Lelievre E., et al. The ciliary neurotrophic factor receptor alpha component induces the secretion of and is required for functional responses to cardiotrophin-like cytokine. EMBO J. 2001, 20:1692-1703.
7. Lelievre E., Plun-Favreau H., Chevalier S., Froger J., Guillet C., Elson G.C., et al. Signaling pathways recruited by the cardiotrophin-like cytokine/cytokine-like factor-1 composite cytokine: specific requirement of the membrane-bound form of ciliary neurotrophic factor receptor alpha component. J. Biol. Chem. 2001, 276:22476-22484.
8. Davis S., Aldrich T.H., Ip N.Y., Stahl N., Scherer S., Farruggella T., et al. Released form of CNTF receptor alpha component as a soluble mediator of CNTF responses. Science 1993, 259:1736-1739.
9. Alexander W.S., Rakar S., Robb L., Farley A., Willson T.A., Zhang J.G., et al. Suckling defect in mice lacking the soluble haemopoietin receptor NR6. Curr. Biol. 1999, 9:605-608.
10. Perret D., Guillet C., Elson G., Froger J., Plun-Favreau H., Rousseau F., et al. Two different contact sites are recruited by cardiotrophin-like cytokine (CLC) to generate the CLC/CLF and CLC/sCNTFRalpha composite cytokines. J. Biol. Chem. 2004, 279:43961-43970.
11. Forger N.G., Prevette D., deLapeyriere O., de Bovis B., Wang S., Bartlett P., et al. Cardiotrophin-like cytokine/cytokine-like factor 1 is an essential trophic factor for lumbar and facial motoneurons in vivo. J. Neurosci. 2003, 23:8854-8858.
12. McGregor N.E., Poulton I.J., Walker E.C., Pompolo S., Quinn J.M., Martin T.J., et al. Ciliary neurotrophic factor inhibits bone formation and plays a sex-specific role in bone growth and remodeling. Calcif. Tissue Int. 2010, 86:261-270.
13. Sleeman M.W., Anderson K.D., Lambert P.D., Yancopoulos G.D., Wiegand S.J. The ciliary neurotrophic factor and its receptor, CNTFR alpha. Pharm. Acta Helv. 2000, 74:265-272.
14. Cognet I., Guilhot F., Gabriac M., Chevalier S., Chouikh Y., Herman-Bert A., et al. Cardiotrophin-like cytokine labelling using Bir A biotin ligase: a sensitive tool to study receptor expression by immune and non-immune cells. J. Immunol. Methods 2005, 301:53-65.
15. Crabe S., Guay-Giroux A., Tormo A.J., Duluc D., Lissilaa R., Guilhot F., et al. The IL-27 p28 subunit binds cytokine-like factor 1 to form a cytokine regulating NK and T cell activities requiring IL-6R for signaling. J. Immunol. 2009, 183:7692-7702.
16. White U.A., Stewart W.C., Mynatt R.L., Stephens J.M. Neuropoietin attenuates adipogenesis and induces insulin resistance in adipocytes. J. Biol. Chem. 2008.
17. White U.A., Stewart W.C., Stephens J.M. Gp130 cytokines exert differential patterns of crosstalk in adipocytes both in vitro and in vivo. Obesity 2011, 19:903-910.
18. White U.A., Stephens J.M. Neuropoietin activates STAT3 independent of LIFR activation in adipocytes. Biochem. Biophys. Res. Commun. 2010, 395:48-50.
19. Blanchard F., Wang Y., Kinzie E., Duplomb L., Godard A., Baumann H., Oncostatin M. regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms. J. Biol. Chem. 2001, 276:47038-47045.
20. Blanchard F., Duplomb L., Wang Y., Robledo O., Kinzie E., Pitard V., et al. Stimulation of leukemia inhibitory factor receptor degradation by extracellular signal-regulated kinase. J. Biol. Chem. 2000, 275:28793-28801.
21. Walker E.C., McGregor N.E., Poulton I.J., Solano M., Pompolo S., Fernandes T.J., et al. Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice. J. Clin. Invest. 2010, 120:582-592.
22. Larsen J.V., Hansen M., Moller B., Madsen P., Scheller J., Nielsen M., et al. Sortilin facilitates signaling of ciliary neurotrophic factor and related helical type 1 cytokines targeting the gp130/leukemia inhibitory factor receptor beta heterodimer. Mol. Cell. Biol. 2010, 30:4175-4187.
23. Mazella J., Zsurger N., Navarro V., Chabry J., Kaghad M., Caput D., et al. The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J. Biol. Chem. 1998, 273:26273-26276.
24. Nykjaer A., Lee R., Teng K.K., Jansen P., Madsen P., Nielsen M.S., et al. Sortilin is essential for proNGF-induced neuronal cell death. Nature 2004, 427:843-848.
25. Petersen C.M., Nielsen M.S., Nykjaer A., Jacobsen L., Tommerup N., Rasmussen H.H., et al. Molecular identification of a novel candidate sorting receptor purified from human brain by receptor-associated protein affinity chromatography. J. Biol. Chem. 1997, 272:3599-3605.
26. Larsen J.V., Hermey G., Sorensen E.S., Prabakaran T., Christensen E.I., Gliemann J., et al. Human sorCS1 binds sortilin and hampers its cellular functions. Biochem. J. 2014, 457:277-288.
27. Knappskog P.M., Majewski J., Livneh A., Nilsen P.T., Bringsli J.S., Ott J., et al. Cold-induced sweating syndrome is caused by mutations in the CRLF1 gene. Am. J. Hum. Genet. 2003, 72:375-383.
28. Rousseau F., Gauchat J.F., McLeod J.G., Chevalier S., Guillet C., Guilhot F., et al. Inactivation of cardiotrophin-like cytokine, a second ligand for ciliary neurotrophic factor receptor, leads to cold-induced sweating syndrome in a patient. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:10068-10073.
29. Takahashi R., Yokoji H., Misawa H., Hayashi M., Hu J., Deguchi T. A null mutation in the human CNTF gene is not causally related to neurological diseases. Nat. Genet. 1994, 7:79-84.
30. Hahn A.F., Jones D.L., Knappskog P.M., Boman H., McLeod J.G. Cold-induced sweating syndrome: a report of two cases and demonstration of genetic heterogeneity. J. Neurol. Sci. 2006, 250:62-70.
31. Piras R., Chiappe F., Torraca I.L., Buers I., Usala G., Angius A., et al. Expanding the mutational spectrum of CRLF1 in Crisponi/CISS1 syndrome. Hum. Mutat. 2014, 35:424-433.
32. Crisponi L., Crisponi G., Meloni A., Toliat M.R., Nurnberg G., Usala G., et al. Crisponi syndrome is caused by mutations in the CRLF1 gene and is allelic to cold-induced sweating syndrome type 1. Am. J. Hum. Genet. 2007, 80:971-981.
33. Herholz J., Meloni A., Marongiu M., Chiappe F., Deiana M., Herrero C.R., et al. Differential secretion of the mutated protein is a major component affecting phenotypic severity in CRLF1-associated disorders. Eur. J. Hum. Genet. 2011, 19:525-533.
34. Dagoneau N., Scheffer D., Huber C., Al-Gazali L.I., Di Rocco M., Godard A., et al. Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome. Am. J. Hum. Genet. 2004, 74:298-305.
35. Poulton I.J., McGregor N.E., Pompolo S., Walker E.C., Sims N.A. Contrasting roles of leukemia inhibitory factor in murine bone development and remodeling involve region-specific changes in vascularization. J. Bone Miner. Res. 2012, 27:586-595.
36. Walker E.C., McGregor N.E., Poulton I.J., Pompolo S., Allan E.H., Quinn J.M., et al. Cardiotrophin-1 is an osteoclast-derived stimulus of bone formation required for normal bone remodeling. J. Bone Miner. Res. 2008, 23:2025-2032.
37. Zou X., Bolon B., Pretorius J.K., Kurahara C., McCabe J., Christiansen K.A., et al. Neonatal death in mice lacking cardiotrophin-like cytokine is associated with multifocal neuronal hypoplasia. Vet. Pathol. 2009, 46:514-519.
38. DeChiara T.M., Vejsada R., Poueymirou W.T., Acheson A., Suri C., Conover J.C., et al. Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell 1995, 83:313-322.
39. Masu Y., Wolf E., Holtmann B., Sendtner M., Brem G., Thoenen H. Disruption of the CNTF gene results in motor neuron degeneration. Nature 1993, 365:27-32.
40. Uemura A., Takizawa T., Ochiai W., Yanagisawa M., Nakashima K., Taga T. Cardiotrophin-like cytokine induces astrocyte differentiation of fetal neuroepithelial cells via activation of STAT3. Cytokine 2002, 18:1-7.
41. Kraves S., Weitz C.J. A role for cardiotrophin-like cytokine in the circadian control of mammalian locomotor activity. Nat. Neurosci. 2006, 9:212-219.
42. Looyenga B.D., Resau J., MacKeigan J.P. Cytokine receptor-like factor 1 (CRLF1) protects against 6-hydroxydopamine toxicity independent of the gp130/JAK signaling pathway. PLOS ONE 2013, 8:e66548.
43. Kaur N., Lu B., Monroe R.K., Ward S.M., Halvorsen S.W. Inducers of oxidative stress block ciliary neurotrophic factor activation of Jak/STAT signaling in neurons. J. Neurochem. 2005, 92:1521-1530.
44. Elsaeidi F., Bemben M.A., Zhao X.F., Goldman D. Jak/Stat signaling stimulates zebrafish optic nerve regeneration and overcomes the inhibitory actions of Socs3 and Sfpq. J. Neurosci. 2014, 34:2632-2644.
45. Barrette B., Calvo E., Vallières N., Lacroix S. Transcriptional profiling of the injured sciatic nerve of mice carrying the Wld(S) mutant gene: identification of genes involved in neuroprotection, neuroinflammation, and nerve regeneration. Brain Behav. Immun. 2010, 24:1254-1267.
46. Elson G.C., Graber P., Losberger C., Herren S., Gretener D., Menoud L.N., et al. Cytokine-like factor-1, a novel soluble protein, shares homology with members of the cytokine type I receptor family. J. Immunol. 1998, 161:1371-1379.
47. Buenzli P.R., Sims N.A. Quantifying the osteocyte network in the human skeleton. Bone 2015, 75:144-150.
48. Clancy B.M., Johnson J.D., Lambert A.J., Rezvankhah S., Wong A., Resmini C., et al. A gene expression profile for endochondral bone formation: oligonucleotide microarrays establish novel connections between known genes and BMP-2-induced bone formation in mouse quadriceps. Bone 2003, 33:46-63.
49. Walker E.C., Poulton I.J., McGregor N.E., Ho P.W., Allan E.H., Quach J.M., et al. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo. J. Bone Miner. Res. 2012, 27:902-912.
50. Standal T., Johnson R.W., McGregor N.E., Poulton I.J., Ho P.W., Martin T.J., et al. Gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation. J. Endocrinol. 2014, 223:181-190.
51. Zhang P., Turner C.H., Yokota H. Joint loading-driven bone formation and signaling pathways predicted from genome-wide expression profiles. Bone 2009, 44:989-998.
52. Sims N.A., Walsh N.C. GP130 cytokines and bone remodelling in health and disease. BMB Rep. 2010, 43:513-523.
53. Johnson R.W., Brennan H.J., Vrahnas C., Poulton I.J., McGregor N.E., Standal T., et al. The primary function of gp130 signaling in osteoblasts is to maintain bone formation and strength, rather than promote osteoclast formation. J. Bone Miner. Res. 2014, 29:1492-1505.
54. Johnson R.W., White J.D., Walker E.C., Martin T.J., Sims N.A. Myokines (muscle-derived cytokines and chemokines) including ciliary neurotrophic factor (CNTF) inhibit osteoblast differentiation. Bone 2014, 64:47-56.
55. Tsuritani K., Takeda J., Sakagami J., Ishii A., Eriksson T., Hara T., et al. Cytokine receptor-like factor 1 is highly expressed in damaged human knee osteoarthritic cartilage and involved in osteoarthritis downstream of TGF-beta. Calcif. Tissue Int. 2010, 86:47-57.
56. Sato T., Konomi K., Yamasaki S., Aratani S., Tsuchimochi K., Yokouchi M., et al. Comparative analysis of gene expression profiles in intact and damaged regions of human osteoarthritic cartilage. Arthritis Rheum. 2006, 54:808-817.
57. Bateman J.F., Rowley L., Belluoccio D., Chan B., Bell K., Fosang A.J., et al. Transcriptomics of wild-type mice and mice lacking ADAMTS-5 activity identifies genes involved in osteoarthritis initiation and cartilage destruction. Arthritis Rheum. 2013, 65:1547-1560.
58. Schmidt-Ott K.M., Yang J., Chen X., Wang H., Paragas N., Mori K., et al. Novel regulators of kidney development from the tips of the ureteric bud. J. Am. Soc. Nephrol. 2005, 16:1993-2002.
59. M. Sharma, J. Zhou, J.-F. Gauchat, R. Sharma, E.T. McCarthy, T. Srivastava, et al., Janus kinase 2/signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier, Transl. Res. (in press).
60. Senaldi G., Stolina M., Guo J., Faggioni R., McCabe S., Kaufman S.A., et al. Regulatory effects of novel neurotrophin-1/b cell-stimulating factor-3 (cardiotrophin-like cytokine) on B cell function. J. Immunol. 2002, 168:5690-5698.
61. Tormo A.J., Meliani Y., Beaupre L.A., Sharma M., Fritz J.H., Elson G., et al. The composite cytokine p28/cytokine-like factor 1 sustains B cell proliferation and promotes plasma cell differentiation. J. Immunol. 2013, 191:1657-1665.
62. Stumhofer J.S., Tait E.D., Quinn W.J., Hosken N., Spudy B., Goenka R., et al. A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat. Immunol. 2010, 11:1119-1126.
63. Calkoen F.G.J., Vervat C., van Pel M., de Haas V., Vijfhuizen L.S., Eising E., et al. Despite differential gene expression profiles pediatric MDS derived mesenchymal stromal cells display functionality in vitro. Stem Cell Res. 2015, 14:198-210.
64. Kass D.J., Yu G., Loh K.S., Savir A., Borczuk A., Kahloon R., et al. Cytokine-like factor 1 gene expression is enriched in idiopathic pulmonary fibrosis and drives the accumulation of CD4+ T cells in murine lungs: evidence for an antifibrotic role in bleomycin injury. Am. J. Pathol. 2012, 180:1963-1978.
65. Vicent S., Sayles L.C., Vaka D., Khatri P., Gevaert O., Chen R., et al. Cross-species functional analysis of cancer-associated fibroblasts identifies a critical role for CLCF1 and IL-6 in non-small cell lung cancer in vivo. Cancer Res. 2012, 72:5744-5756.
66. McNally R.S., Davis B.K., Clements C.M., Accavitti-Loper M.A., Mak T.W., Ting J.P.-Y. DJ-1 enhances cell survival through the binding of Cezanne, a negative regulator of NF-κB. J. Biol. Chem. 2011, 286:4098-4106.
67. Ohno M., Kohyama J., Namihira M., Sanosaka T., Takahashi J.A., Hashimoto N., et al. Neuropoietin induces neuroepithelial cells to differentiate into astrocytes via activation of STAT3. Cytokine 2006, 36:17-22.
68. Zvonic S., Cornelius P., Stewart W.C., Mynatt R.L., Stephens J.M. The regulation and activation of ciliary neurotrophic factor signaling proteins in adipocytes. J. Biol. Chem. 2003, 278:2228-2235.